simvastatin
simvastatin.JPG

CLINICAL USE

HMG CoA reductase inhibitor:Primary hypercholesterolaemia

DOSE IN NORMAL RENAL FUNCTION

10–80 mg at night

PHARMACOKINETICS

  • Molecular weight                           :418.6
  • %Protein binding                           :>95
  • %Excreted unchanged in urine     : 13
  • Volume of distribution (L/kg)       :54
  • half-life – normal/ESRD (hrs)      :1.9/–

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           :
  • 10 to 20     : mg daily. In severe renal impairment doses above 10 mg should be used with caution (doses up to 40 mg have been used)

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unlikely to be dialysed. Dose as in GFR <10 mL/min
  • HD                     :Unlikely to be dialysed. Dose as in GFR <10 mL/min
  • HDF/high flux   :Unknown dialysability. Dose as in GFR <10 mL/min
  • CAV/VVHD      :Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Anti-arrhythmics: increased risk of myopathy with amiodarone – do not exceed 20 mg of simvastatin.1
  • Antibacterials: increased risk of myopathy with clarithromycin, daptomycin, telithromycin and erythromycin – avoid concomitant use; increased risk of myopathy with fusidic acid
  • Anticoagulants: effects of coumarins enhanced
  • Antifungals: increased risk of myopathy with itraconazole, posaconazole or ketoconazole and possibly miconazole – avoid concomitant use; possibly increased risk of myopathy with imidazoles and triazoles
  • Antivirals: increased risk of myopathy with atazanavir, indinavir, nelfinavir, ritonavir or saquinavir and possibly amprenavir or lopinavir – avoid concomitant use; concentration reduced by efavirenz
  • Calcium-channel blockers: increased risk of myopathy with verapamil and possibly diltiazem – do not exceed 20 mg of simvastatin with verapamil or 40 mg with diltiazem.1
  • Ciclosporin: increased risk of myopathy – do not exceed 10 mg of simvastatin.1Grapefruit: increased risk of myopathy – avoid concomitant useHormone antagonists: possibly increased risk of myopathy with danazol – do not exceed 10 mg of simvastatin.1Lipid-lowering agents: increased risk of myopathy with fibrates – do not exceed 10 mg of simvastatin except with fenofibrate;1 gemfibrozil –avoid; and nicotinic acid

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION





    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs